ProKidney Statistics
Total Valuation
ProKidney has a market cap or net worth of $216.81 million. The enterprise value is $1.24 billion.
Important Dates
The next estimated earnings date is Tuesday, November 12, 2024, before market open.
| Earnings Date | Nov 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ProKidney has 126.05 million shares outstanding. The number of shares has increased by 0.96% in one year.
| Shares Outstanding | 126.05M |
| Shares Change (YoY) | +0.96% |
| Shares Change (QoQ) | +24.54% |
| Owned by Insiders (%) | 21.28% |
| Owned by Institutions (%) | 33.78% |
| Float | 68.47M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 21.87, with a Debt / Equity ratio of 0.01.
| Current Ratio | 21.87 |
| Quick Ratio | 21.09 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15,395.90 |
Financial Efficiency
Return on equity (ROE) is -29.59% and return on invested capital (ROIC) is -20.50%.
| Return on Equity (ROE) | -29.59% |
| Return on Assets (ROA) | -19.57% |
| Return on Capital (ROIC) | -20.50% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$237,319 |
| Employee Count | 163 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ProKidney has paid $3.75 million in taxes.
| Income Tax | 3.75M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +14.29% in the last 52 weeks. The beta is 1.28, so ProKidney's price volatility has been higher than the market average.
| Beta (5Y) | 1.28 |
| 52-Week Price Change | +14.29% |
| 50-Day Moving Average | 2.07 |
| 200-Day Moving Average | 2.13 |
| Relative Strength Index (RSI) | 42.32 |
| Average Volume (20 Days) | 428,384 |
Short Selling Information
The latest short interest is 10.74 million, so 8.52% of the outstanding shares have been sold short.
| Short Interest | 10.74M |
| Short Previous Month | 10.02M |
| Short % of Shares Out | 8.52% |
| Short % of Float | 15.68% |
| Short Ratio (days to cover) | 9.03 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -153.96M |
| Pretax Income | -34.94M |
| Net Income | -38.68M |
| EBITDA | -149.44M |
| EBIT | -153.96M |
| Earnings Per Share (EPS) | -$0.61 |
Full Income StatementBalance Sheet
The company has $431.53 million in cash and $6.67 million in debt, giving a net cash position of $424.86 million or $3.37 per share.
| Cash & Cash Equivalents | 431.53M |
| Total Debt | 6.67M |
| Net Cash | 424.86M |
| Net Cash Per Share | $3.37 |
| Equity (Book Value) | 472.37M |
| Book Value Per Share | -7.73 |
| Working Capital | 429.67M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$122.10 million and capital expenditures -$31.11 million, giving a free cash flow of -$153.21 million.
| Operating Cash Flow | -122.10M |
| Capital Expenditures | -31.11M |
| Free Cash Flow | -153.21M |
| FCF Per Share | -$1.22 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |